Tag: Cancer: Colon
FTD-TPI Plus Bevacizumab Increases Survival in Refractory Advanced CRC
Significantly longer overall survival and progression-free survival seen for combination versus TFD-TPI alone
Risk for Early-Onset CRC Increased in Women Born Via C-Section
Authors say finding may be explained by early-life gut dysbiosis
Prediagnostic Weight Loss Underestimates Risk for Colorectal Cancer
Association for high BMI and colorectal cancer risk most pronounced using BMI at least eight years before diagnosis
Partners of CRC Survivors Experience Long-Term Financial Toxicity
Furthermore, this financial toxicity is associated with worse health-related quality of life
Physical Activity May Prevent Colon Cancer Recurrence
Lower recurrence rate seen within the first year of treatment among those with higher physical activity
Higher Risk for CRC Seen in Adults Exposed to Bendectin In Utero
Risk of colorectal cancer higher in offspring exposed in utero during 1960s versus unexposed offspring
CRC Incidence Shifting to Younger Adults, More Advanced Disease
Incidence increased for those younger than 65 years for regional-stage and distant-stage disease since 2010, reversing previous shift to earlier-stage disease
Adenoma Detection Rate Inversely Linked to Postcolonoscopy CRC
Inverse association seen for ADR with postcolonoscopy colorectal cancer incidence risk in FIT-based screening program setting
Defensive Information Processing Is Barrier to CRC Screening Uptake
Odds of FIT-based screening lower with suppression subdomains of 'deny immediacy to be tested' and 'self-exemption'
Neoadjuvant Oxaliplatin-Fluoropyrimidine Chemo Improves Colon Cancer Outcomes
Benefits include histopathologic downstaging, fewer incomplete resections, and better two-year disease control
